Literature DB >> 15534089

Angiogenic profile of breast carcinoma determines leukocyte infiltration.

Jessica C A Bouma-ter Steege1, Coen I M Baeten, Victor L J L Thijssen, Sietske A Satijn, Inge C L Verhoeven, Harry F P Hillen, John Wagstaff, Arjan W Griffioen.   

Abstract

To study the relationship between the angiogenic profile and leukocyte infiltration of tumors, single cell suspensions of archival frozen medullary and ductal breast cancer tissues were analyzed by flow cytometry. The amount of leukocytes and endothelial cells was measured, as well as the expression of intercellular adhesion molecule-1 (ICAM-1) on the endothelial cell fraction. A significantly higher number (3.2-fold) of infiltrating leukocytes was observed in medullary carcinoma. The composition of this infiltrate was similar to that seen in ductal carcinomas. The more intense infiltrate was explained by the approximately 3-fold enhanced endothelial ICAM-1 expression in medullary carcinoma. The angiogenic profile of all tumors was assessed by quantitative real-time reverse transcription-PCR analysis. Vascular endothelial growth factor (VEGF)-C and VEGF-D, but not VEGF-A, basic fibroblast growth factor, placental growth factor, and angiopoietins 1, 2, and 3 showed a relatively higher level of expression in ductal carcinoma than in medullary carcinoma. In vitro, both VEGF-C and VEGF-D were found to decrease endothelial ICAM-1 expression in the presence of basic fibroblast growth factor. These data suggest that in vivo angiogenic stimuli prevent the formation of an effective leukocyte infiltrate in tumors by suppressing endothelial ICAM-1 expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15534089     DOI: 10.1158/1078-0432.CCR-04-0742

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  20 in total

1.  Expression of VEGFR3 in glioma endothelium correlates with tumor grade.

Authors:  S J Grau; F Trillsch; J Herms; N Thon; P J Nelson; J-C Tonn; R Goldbrunner
Journal:  J Neurooncol       Date:  2006-11-17       Impact factor: 4.130

2.  Mimicking the tumor microenvironment to regulate macrophage phenotype and assessing chemotherapeutic efficacy in embedded cancer cell/macrophage spheroid models.

Authors:  Kristie M Tevis; Ryan J Cecchi; Yolonda L Colson; Mark W Grinstaff
Journal:  Acta Biomater       Date:  2016-12-21       Impact factor: 8.947

Review 3.  Anti-angiogenic agents - overcoming tumour endothelial cell anergy and improving immunotherapy outcomes.

Authors:  Zowi R Huinen; Elisabeth J M Huijbers; Judy R van Beijnum; Patrycja Nowak-Sliwinska; Arjan W Griffioen
Journal:  Nat Rev Clin Oncol       Date:  2021-04-08       Impact factor: 66.675

4.  The parallel lives of angiogenesis and immunosuppression: cancer and other tales.

Authors:  Gregory T Motz; George Coukos
Journal:  Nat Rev Immunol       Date:  2011-09-23       Impact factor: 53.106

5.  Genetic Variations of Kinase Inserts Domain Receptor (KDR) Gene Are Associated with the Risk of Astrocytomas.

Authors:  Yufei Gao; Piyong Ma; Yichun He; Yan Liu; Yang Jiang
Journal:  Mol Neurobiol       Date:  2015-06-17       Impact factor: 5.590

Review 6.  Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors.

Authors:  Seth B Coffelt; Claire E Lewis; Luigi Naldini; J Martin Brown; Napoleone Ferrara; Michele De Palma
Journal:  Am J Pathol       Date:  2010-02-18       Impact factor: 4.307

Review 7.  Preconditioning thermal therapy: flipping the switch on IL-6 for anti-tumour immunity.

Authors:  Maryann E Mikucki; Daniel T Fisher; Amy W Ku; Michelle M Appenheimer; Jason B Muhitch; Sharon S Evans
Journal:  Int J Hyperthermia       Date:  2013-07-17       Impact factor: 3.914

8.  Heterogeneity of mammary lesions represent molecular differences.

Authors:  Ruria Namba; Jeannie E Maglione; Ryan R Davis; Colin A Baron; Stephenie Liu; Condie E Carmack; Lawrence J T Young; Alexander D Borowsky; Robert D Cardiff; Jeffrey P Gregg
Journal:  BMC Cancer       Date:  2006-12-05       Impact factor: 4.430

9.  Macrophages promote angiogenesis in human breast tumour spheroids in vivo.

Authors:  L Bingle; C E Lewis; K P Corke; M W R Reed; N J Brown
Journal:  Br J Cancer       Date:  2006-01-16       Impact factor: 7.640

Review 10.  Anti-angiogenesis: making the tumor vulnerable to the immune system.

Authors:  Arjan W Griffioen
Journal:  Cancer Immunol Immunother       Date:  2008-04-26       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.